How Are BPC-157 and TB-500 Dosed When Combined
For the outer thigh in lean patients, 45 degrees with a pinch is the safer choice
ZhaoJTaverneMAVan Der WeijdenGCBeversMMVan Den HurkR
However, optimal success is associated with intravenous or subcutaneous injection , because these delivery methods have a high bioavailability
REDEFINE 1: CagriSema in overweight or obesity, NEJM full text REDEFINE 1: PubMed 40544433 REDEFINE 2: CagriSema in type 2 diabetes and obesity, NEJM full text REDEFINE 2: PubMed 40544432 Phase 1b: cagrilintide co-administered with semaglutide 2.4 mg, The Lancet (2021) Phase 2: once-weekly cagrilintide dose-finding, The Lancet (2021) REDEFINE 1 trial record: NCT05567796 Phase 2 trial record: NCT03856047 Phase 1b trial record: NCT03600480 Novo Nordisk files for FDA approval of CagriSema: press release (Dec 2025) CagriSema regulatory history: Drugs.com The 0.25 2.4 mg four-week ladder is stated explicitly in both NEJM papers, for the fixed-dose combination pen
Practitioners often tailor dose, route, and injection site to the target tissue